Study could explain why Parkinson's drug improves, then diminishes quality of life
A team of University of California, Irvine researchers has discovered a possible reason why L-dopa, the front-line drug for treating Parkinson's disease, loses efficacy and causes dyskinesia—involuntary, erratic muscle ...
Jan 20, 2022
0
254